Dr Laurence Bishop Attends BioJapan Online

Dr Laurence Bishop will be attending BioJapan online between 14th and the 16th of October 2020. BioJapan is being held at the Pacifico Yokohama in Japan this year and will be a hybrid of partnering taking place online and onsite. Some companies are exhibiting live and there will also be a mixture of live and [...]

By |2020-10-08T16:38:40+01:00October 8th, 2020|Events|Comments Off on Dr Laurence Bishop Attends BioJapan Online

ApconiX Welcomes Simon Craige to the Team

ApconiX is delighted to welcome Simon Craige to the team. Simon has over 15 years’ nonclinical and toxicology experience working in several medical and pharmaceutical organisations across multiple disciplines including small molecules, vaccines, biologics, and medical devices.  He has experience of a diverse range of therapeutic areas including oncology, CNS, ocular and dermal in drug [...]

By |2020-10-12T17:30:30+01:00September 30th, 2020|Careers|Comments Off on ApconiX Welcomes Simon Craige to the Team

Improve Drug Project Success by Understanding Drug Target Safety

Join Professor Ruth Roberts, Director and Co-founder, ApconiX Ltd, Dr Claire Sadler, Project Toxicologist, ApconiX and Dr Leigh Ann Burns Nass, President/Owner, Magnolia Toxicology Consulting, LLC in a live webinar on Thursday, October 1, 2020 at 11am EDT (4pm BST/UK) In this free webinar, hosted by XTALKS, the speakers will explore data access and interpretation using [...]

By |2020-10-12T17:32:20+01:00September 24th, 2020|Uncategorised|Comments Off on Improve Drug Project Success by Understanding Drug Target Safety

22nd Annual John Doull Symposium

Professor Ruth Roberts is guest speaker at the 22nd Annual John Doull Toxicology Symposium.  This event is taking place on the 29th of September at 9am CDT.  The Symposium is part of the University of Kansas, School of Medicine, Pharmacology, Toxicology & Therapeutics' series of seminars. Attendance is limited but if you are interested please [...]

By |2020-10-12T17:33:05+01:00September 17th, 2020|Events|Comments Off on 22nd Annual John Doull Symposium

Dr Michael Morton is Attending Safety Pharmacology Society

Dr Michael Morton will be attending the annual Safety Pharmacology Society Meeting being held virtually this year between 14th and 17th of September. Mike will be presenting Poster 030: Electrophysiological analysis of Seroquel’s activity in sodium ion channels, CiPA ion channels and hiPSC-neuronal cells K L Rockley1; K Jones1; R A Roberts1; M J Morton1 [...]

By |2020-10-12T17:34:16+01:00September 10th, 2020|Events|Comments Off on Dr Michael Morton is Attending Safety Pharmacology Society

ApconiX Welcomes Dr Duncan Armstrong

ApconiX is delighted to welcome Dr Duncan Armstrong to the team. Duncan has expert knowledge in molecular pharmacology, preclinical safety pharmacology and secondary pharmacodynamics gained over 18 years working in drug discovery and development at AstraZeneca UK and Novartis USA. He has worked with project teams across multiple therapy areas and at all stages of [...]

By |2020-09-09T14:15:45+01:00September 9th, 2020|Careers|Comments Off on ApconiX Welcomes Dr Duncan Armstrong

Join Dr Richard Knight at the Digital AMR Conference

Join Dr Richard Knight, Co-founder and Director of ApconiX, Dr Peter Warn consultant at Magic Bullet Consulting, and Aleksander Danilovski, Chief Scientific Officer & Senior Vice President, Global R&D and Regulatory Affairs at Xelia at the 4th AMR Conference as they discuss the "Top 10 Mistakes in Antibacterial Development". In view of the continuing uncertain situation [...]

By |2020-08-20T10:44:53+01:00August 19th, 2020|Events|Comments Off on Join Dr Richard Knight at the Digital AMR Conference

Science-Driven Design of the Preclinical Strategy: Case by Case

Join Professor Ruth Roberts for the next science webinar in the Alderley Park Science Seminar Series: Science-Driven Design of the Preclinical Strategy: Case by Case Tuesday, 11 August 2020 12:00 pm to 1:00 pm Ruth will present lessons learned from >20 years’ experience in the pharmaceutical industry focusing on attrition, prediction and the challenges posed by nonclinical [...]

By |2020-08-05T14:01:54+01:00August 5th, 2020|Events|Comments Off on Science-Driven Design of the Preclinical Strategy: Case by Case

Discover the Power of Target Safety Assessments in a SOT EHS Webinar

Professor Ruth Roberts, Dr Claire Sadler and Dr Leigh Ann Burns Nass present Target Safety Assessments: Knowledge is Power webinar in a SOT 2020 Exhibitor Hosted Session.  Membership of SOT is not required.  Registration for the webinar is free.  

By |2020-07-02T15:47:19+01:00July 2nd, 2020|Events|Comments Off on Discover the Power of Target Safety Assessments in a SOT EHS Webinar

ApconiX Welcomes Dr Laurence Bishop

ApconiX is delighted to welcome Dr Laurence Bishop to the team as our Head of Business Development.  Laurence is an experienced DMPK and toxicological scientist with 20 years’ experience of nonclinical drug development.  Specialising in business development for the past 13 years, we are looking forward to Laurence playing a key role in our growth [...]

By |2020-05-28T17:27:19+01:00May 28th, 2020|Careers|Comments Off on ApconiX Welcomes Dr Laurence Bishop